🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/05/2003 33,24 36,84 32,64 36,06 +8,68% 12,64% 246.383
09/05/2003 33,06 33,54 32,58 33,18 -0,18% 2,90% 79.517
08/05/2003 32,52 33,48 31,50 33,24 +0,73% 6,09% 114.617
07/05/2003 32,70 33,90 32,40 33,00 +1,85% 4,59% 161.750
06/05/2003 33,72 34,50 31,50 32,40 -2,17% 8,90% 237.033
05/05/2003 32,70 34,56 31,50 33,12 +2,03% 9,36% 436.200
02/05/2003 36,90 36,90 31,80 32,46 -11,02% 13,82% 365.983
01/05/2003 39,72 40,02 36,24 36,48 -3,18% 9,52% 443.167
30/04/2003 36,66 41,34 34,50 37,68 +11,94% 18,66% 1.072.100
29/04/2003 37,08 37,50 33,30 33,66 -7,58% 11,33% 256.400
28/04/2003 36,42 38,94 34,20 36,42 -13,90% 13,01% 918.533
25/04/2003 31,20 42,48 30,90 42,30 +37,16% 37,12% 1.150.833
24/04/2003 31,80 31,86 29,58 30,84 +8,44% 7,17% 155.700
23/04/2003 27,00 28,50 26,70 28,44 +6,76% 6,67% 79.450
22/04/2003 26,64 26,70 25,20 26,64 +2,07% 5,63% 62.783
21/04/2003 25,50 27,54 25,26 26,10 +3,57% 8,94% 91.917
17/04/2003 24,84 26,16 24,12 25,20 +1,20% 8,21% 71.233
16/04/2003 23,22 25,08 22,26 24,90 +5,33% 12,14% 43.133
15/04/2003 25,20 25,26 23,40 23,64 -5,29% 7,38% 42.900
14/04/2003 24,00 25,50 23,58 24,96 +7,49% 8,00% 75.967
11/04/2003 23,40 24,60 22,80 23,22 -1,53% 7,69% 88.900
10/04/2003 21,30 23,58 20,28 23,58 +15,59% 15,49% 86.583
09/04/2003 20,88 20,88 19,50 20,40 -2,30% 6,61% 22.567
08/04/2003 19,86 21,66 19,14 20,88 +3,26% 12,69% 50.300
07/04/2003 23,10 23,10 19,26 20,22 -8,17% 16,62% 83.583
04/04/2003 21,84 22,02 21,24 22,02 +1,10% 3,57% 44.433
03/04/2003 20,10 21,90 19,26 21,78 +9,67% 13,13% 93.333
02/04/2003 20,40 21,90 19,50 19,86 -0,90% 11,76% 89.767
01/04/2003 20,70 22,50 19,02 20,04 -3,19% 16,81% 202.467
31/03/2003 17,70 21,60 15,90 20,70 +25,00% 32,20% 196.517